Novel mRNA biomarker-based liquid biopsy for the detection of resectable pancreatic cancer
Compared to CA19-9, the mRNA biomarker panel, HELP-15, improved diagnostic performance in patients with RPC, particularly in those with normal CA19-9 levels.
Authors
- Kwangrok Jung (ORCID: https://orcid.org/0000-0002-2178-548X)
- Hyoung Hwa Jeong
- Eun-Jin Sim (ORCID: https://orcid.org/0000-0002-9803-3331)
- Sung‐Hyeok Hong
- Yuna Youn (ORCID: https://orcid.org/0000-0002-1026-6748)
- Sara Koo (ORCID: https://orcid.org/0000-0001-7383-3140)
- Jin‐Hyeok Hwang (ORCID: https://orcid.org/0000-0002-5643-8461)
- Jihie Kim (ORCID: https://orcid.org/0000-0003-2358-4021)
- Jin‐Sik Bae
- Sung Won Kang
- Yun‐Ji Kim (ORCID: https://orcid.org/0000-0002-0003-8880)
- Seong Young Kwon (ORCID: https://orcid.org/0000-0002-2832-896X)
- Jong-chan Lee
- Jaihwan Kim
- Mun-sub Byoun
Institutions
- Seoul National University (KR)
- Dongguk University (KR)
- Seoul National University Bundang Hospital (KR)
- National University College (PR)
- Bio-Medical Science (South Korea) (KR)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1186/s12885-025-14124-w
- Citations
- 3
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 3.14
Funders
- Iran Telecommunication Research Center
- Ministry of Science and ICT, South Korea
- Institute for Information and Communications Technology Promotion